Robert J.C. Slebos

3.5k total citations · 1 hit paper
24 papers, 2.7k citations indexed

About

Robert J.C. Slebos is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Robert J.C. Slebos has authored 24 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Pulmonary and Respiratory Medicine and 11 papers in Oncology. Recurrent topics in Robert J.C. Slebos's work include Lung Cancer Treatments and Mutations (12 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Cancer-related Molecular Pathways (4 papers). Robert J.C. Slebos is often cited by papers focused on Lung Cancer Treatments and Mutations (12 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Cancer-related Molecular Pathways (4 papers). Robert J.C. Slebos collaborates with scholars based in Netherlands, United States and Denmark. Robert J.C. Slebos's co-authors include Sjoerd Rodenhuis, Lora Hedrick, Michael B. Kastan, Theodore D. Kessis, Kathleen R. Cho, Beverly Plunkett, Wolter J. Mooi, Nico van Zandwijk, Johannes L. Bos and R.E. Kibbelaar and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Robert J.C. Slebos

24 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

K-rasOncogene Activation as a Prognostic Marker in Adenocarcinoma of the Lung

1990 643 citations Robert J.C. Slebos, R.E. Kibbelaar et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert J.C. Slebos Netherlands	18	1.5k	1.4k	903	561	415	24	2.7k
Mark L. Levitt United States	16	1.1k 0.7×	799 0.6×	464 0.5×	349 0.6×	202 0.5×	43	1.9k
Sylvie Gazzéri France	36	1.6k 1.0×	2.5k 1.9×	581 0.6×	677 1.2×	168 0.4×	63	3.5k
Peter vanTuinen United States	14	1.3k 0.8×	1.1k 0.8×	303 0.3×	584 1.0×	602 1.5×	25	2.5k
A K Virmani United States	20	1.1k 0.7×	3.3k 2.4×	817 0.9×	924 1.6×	406 1.0×	25	4.3k
Sun W. Tam United States	14	2.1k 1.4×	2.2k 1.6×	246 0.3×	394 0.7×	278 0.7×	17	3.2k
Birgitte Smith‐Sørensen Norway	17	1.4k 1.0×	1.4k 1.0×	299 0.3×	674 1.2×	251 0.6×	25	2.4k
Teruhiko Yoshida Japan	24	1.1k 0.7×	1.1k 0.8×	974 1.1×	464 0.8×	191 0.5×	54	2.2k
Julie Izzo United States	31	1.3k 0.9×	1.5k 1.1×	680 0.8×	565 1.0×	231 0.6×	57	2.9k
Ryo Miyahara Japan	35	1.5k 1.0×	1.1k 0.8×	1.4k 1.5×	591 1.1×	154 0.4×	101	3.3k
Yasushi Kasai Japan	27	721 0.5×	1.1k 0.8×	427 0.5×	368 0.7×	191 0.5×	64	2.1k

Countries citing papers authored by Robert J.C. Slebos

Since Specialization

Citations

This map shows the geographic impact of Robert J.C. Slebos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J.C. Slebos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J.C. Slebos more than expected).

Fields of papers citing papers by Robert J.C. Slebos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J.C. Slebos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J.C. Slebos. The network helps show where Robert J.C. Slebos may publish in the future.

Co-authorship network of co-authors of Robert J.C. Slebos

This figure shows the co-authorship network connecting the top 25 collaborators of Robert J.C. Slebos. A scholar is included among the top collaborators of Robert J.C. Slebos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert J.C. Slebos. Robert J.C. Slebos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Chung, Christine H., Ju‐Whei Lee, Robert J.C. Slebos, et al.. (2014). A 3′-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma. Annals of Oncology. 25(11). 2230–2236. 32 indexed citations

2.

Gilbert, Jill, Barbara A. Murphy, Mary S. Dietrich, et al.. (2011). Phase 2 trial of oxaliplatin and pemetrexed as an induction regimen in locally advanced head and neck cancer. Cancer. 118(4). 1007–1013. 14 indexed citations

3.

Whigham, Amy S., James L. Netterville, Brian B. Burkey, et al.. (2006). P193 Short-term Culture and In Vivo Modeling of Primary Head and Neck Squamous Cell Carcinoma. Archives of Otolaryngology - Head and Neck Surgery. 132(8). 901–901. 1 indexed citations

4.

Rodenhuis, Sjoerd, Lucie Boerrigter, Bert Top, et al.. (1997). Mutational activation of the K-ras oncogene and the effect of chemotherapy in advanced adenocarcinoma of the lung: a prospective study.. Journal of Clinical Oncology. 15(1). 285–291. 73 indexed citations

5.

Slebos, Robert J.C., Beverly Plunkett, Theodore D. Kessis, et al.. (1994). p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein.. Proceedings of the National Academy of Sciences. 91(12). 5320–5324. 293 indexed citations

6.

Westra, William H., G.J.A. Offerhaus, Steven N. Goodman, et al.. (1993). Overexpression of the p53 Tumor Suppressor Gene Product in Primary Lung Adenocarcinomas Is Associated with Cigarette Smoking. The American Journal of Surgical Pathology. 17(3). 213–220. 79 indexed citations

7.

Rodenhuis, Sjoerd & Robert J.C. Slebos. (1993). Clinical significance of ras oncogene activation in human lung cancer. Lung Cancer. 8(5-6). 338–338. 284 indexed citations

8.

Kessis, Theodore D., Robert J.C. Slebos, William G. Nelson, et al.. (1993). Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage.. Proceedings of the National Academy of Sciences. 90(9). 3988–3992. 443 indexed citations

9.

Rodenhuis, Sjoerd, Peter C. Groot, Gajja S. Salomons, & Robert J.C. Slebos. (1993). ras oncogene activation and the expression of ras-related genes in human lung cancer. Lung Cancer. 9(1-6). 59–67. 2 indexed citations

10.

Slebos, Robert J.C., et al.. (1992). A Rapid and Simple Procedure for the Routine Detection of ras Point Mutations in Formalin-Fixed, Paraffin-Embedded Tissues. Diagnostic Molecular Pathology. 1(1). 136–141. 2 indexed citations

11.

Slebos, Robert J.C., et al.. (1992). A Rapid and Simple Procedure for the Routine Detection of ras Point Mutations in Formalin-Fixed, Paraffin-Embedded Tissues. Diagnostic Molecular Pathology. 1(1). 136–141. 42 indexed citations

12.

Slebos, Robert J.C., et al.. (1991). Radiosensitivity of small‐cell lung cancer xenografts compared with activity of c‐myc, N‐myc, L‐myc, c‐raf‐1 and K‐ras proto‐oncogenes. International Journal of Cancer. 49(2). 279–284. 14 indexed citations

13.

Slebos, Robert J.C., Gaston Habets, Siegina G. Evers, Wolter J. Mooi, & Sjoerd Rodenhuis. (1991). Allele‐specific detection of K‐ras oncogene expression in human non‐small‐cell lung carcinomas. International Journal of Cancer. 48(1). 51–56. 8 indexed citations

14.

Oudejans, Joost J., Robert J.C. Slebos, F.A.N. Zoetmulder, Wolter J. Mooi, & Sjoerd Rodenhuis. (1991). Differential activation of ras genes by point mutation in human colon cancer with metastases to either lung or liver. International Journal of Cancer. 49(6). 875–879. 83 indexed citations

15.

Breuer, M., Ellen Wientjens, Sjef Verbeek, Robert J.C. Slebos, & A Berns. (1991). Carcinogen-induced lymphomagenesis in pim-1 transgenic mice: dose dependence and involvement of myc and ras.. PubMed. 51(3). 958–63. 62 indexed citations

16.

Rodenhuis, Sjoerd & Robert J.C. Slebos. (1990). The ras Oncogenes in Human Lung Cancer. American Review of Respiratory Disease. 142(6_pt_2). S27–S30. 96 indexed citations

17.

Slebos, Robert J.C., R.E. Kibbelaar, Otilia Dalesio, et al.. (1990). K-rasOncogene Activation as a Prognostic Marker in Adenocarcinoma of the Lung. New England Journal of Medicine. 323(9). 561–565. 643 indexed citations breakdown →

18.

Breuer, Marco L., Robert J.C. Slebos, Sjef Verbeek, et al.. (1989). Very high frequency of lymphoma induction by a chemical carcinogen in pim-1 transgenic mice. Nature. 340(6228). 61–63. 116 indexed citations

19.

Graeff, Alexander de, Robert J.C. Slebos, & Sjoerd Rodenhuis. (1988). Resistance ot cisplatin and analogues: mechanisms and potential clinical implications. Cancer Chemotherapy and Pharmacology. 22(4). 325–332. 85 indexed citations

20.

Höppener, Jo W.M., P.H. Steenbergh, Robert J.C. Slebos, et al.. (1987). Expression of insulin‐like growth factor‐I and ‐II genes in rat medullary thyroid carcinoma. FEBS Letters. 215(1). 122–126. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact